STAT Plus: FDA warns testing companies: Don’t tell patients how their DNA influences response to specific drugs
The FDA is concerned that unsupported claims about gene-drug links could be dangerous, spurring patients to start, stop, or switch medicine inappropriately.
No hay comentarios:
Publicar un comentario